Amylin, a hormone that controls appetite and blood sugar by activating three different receptors in the brain, could be the basis for the next blockbuster obesity drugs. A University of Oklahoma study published today in the journal Science Signaling reveals a new understanding of how amylin receptors react upon being activated, an advancement that will be crucial to the field of drug development.

The University of Oklahoma College of Dentistry has earned a five-year, $2.1 million grant from the Health Resources and Services Administration (HRSA) to expand the workforce of pediatric dentists in Oklahoma and increase access to comprehensive oral health care.

While smoking rates in the United States have substantially declined over the past six decades, smoking remains high among people with low incomes, leading to health disparities. A smartphone app that delivers real-time, tailored messages may hold the key to helping them quit, according to University of Oklahoma clinical trial results published today in JAMA Network Open.

University of Oklahoma researchers are conducting a first-of-its-kind study to determine whether cannabis use affects recovery from the wounds associated with head and neck cancer surgery. The outcomes may have implications for other types of surgery and conditions.

With roughly one-quarter of the University of Oklahoma’s research rooted in AI, OU is harnessing its transformative power across fields to drive real-world solutions and equip students to thrive as professionals and citizens amid rapid technological change. To expand AI-driven innovation at the university and further a commitment to providing students with a leading AI education, OU has named Shishir Shah, Ph.D., as the first university-wide Chief Artificial Intelligence Officer, pending OU Regents’ approval.